Out of Academia

In a blog post at DeviceRandom, Massimo Sandal says why he left not only his chemistry postdoc at the University of Cambridge, but also why he chose to leave academia altogether. While he wasn't overly optimistic about his most recent research project, Sandal says he chose to leave the lab because he thinks there are problems within the "practice of science itself." While he says he still loves science, he's not so enamored with the high-stakes "competition for funding and positions" he's seen within it.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.